Assembly Biosciences (ASMB) Share-based Compensation (2010 - 2026)

Assembly Biosciences' Share-based Compensation history runs 17 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 56.74% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $404000.0 (down 79.16% YoY), while the FY2024 annual figure was $2.0 million, down 61.59% from the prior year.
• Share-based Compensation for Q1 2026 stood at $1.1 million, up from -$3.2 million in the prior quarter.
• The five-year high for Share-based Compensation was $1.8 million in Q1 2023, with the low at -$3.2 million in Q4 2025.
• The 5-year median for Share-based Compensation is $1.0 million (2023), against an average of $798812.5.
• The sharpest annual moves came in 2022 and 2025: Share-based Compensation surged 604.55% in 2022, then tumbled 698.01% in 2025.
• Assembly Biosciences' Share-based Compensation stood at $1.6 million in 2022, then plunged by 38.37% to $959000.0 in 2023, then plunged by 142.02% to -$403000.0 in 2024, then sank by 698.01% to -$3.2 million in 2025, then surged by 134.7% to $1.1 million in 2026.
• Business Quant data shows ASMB's Share-based Compensation at $1.1 million in Q1 2026, -$3.2 million in Q4 2025, and $1.7 million in Q3 2025.